Banco BBVA Argentina S.A. (BBAR)

Ligand Pharmaceuticals Income Statement

Financials in millions ARS. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Interest Income on Loans	3,623,823	4,696,242	6,933,450	1,959,831	418,342	348,485
Total Interest Income	3,623,823	4,696,242	6,933,450	1,959,831	418,342	348,485
Interest Paid on Deposits	1,377,790	1,763,175	3,386,244	902,796	178,059	121,937
Total Interest Expense	1,377,790	1,763,175	3,386,244	902,796	178,059	121,937
Net Interest Income	2,246,033	2,933,067	3,547,206	1,057,036	240,283	226,548
Net Interest Income Growth (YoY)	-46.17%	-17.31%	235.58%	339.91%	6.06%	149.84%
Gain (Loss) on Sale of Assets	-37,588	-37,588	-518.96	1,420	-75.82	-
Gain (Loss) on Sale of Investments	384,391	402,366	-16,563	52,546	-238.23	-6,792
Other Non-Interest Income	463,499	466,981	959,292	240,154	80,695	105,936
Total Non-Interest Income	810,302	831,760	942,210	294,119	80,381	99,145
Non-Interest Income Growth (YoY)	-26.89%	-11.72%	220.35%	265.91%	-18.93%	77.24%
Revenues Before Loan Losses	3,056,335	3,764,827	4,489,416	1,351,155	320,664	325,693
Provision for Loan Losses	271,572	217,656	166,331	60,663	24,880	34,886
Revenue	2,784,763	3,547,171	4,323,085	1,290,492	295,784	290,807
Revenue Growth (YoY)	-45.50%	-17.95%	235.00%	336.30%	1.71%	126.81%
Salaries and Employee Benefits	496,746	515,595	540,272	211,686	61,121	59,920
Occupancy Expenses	84,361	79,612	62,449	34,171	10,873	11,955
Selling, General & Administrative	445,189	440,127	428,440	167,169	49,691	41,955
Other Non-Interest Expense	1,273,837	2,063,270	2,631,200	671,390	141,878	113,176
Total Non-Interest Expense	2,294,844	3,098,553	3,659,842	1,085,869	263,672	226,221
EBT Excluding Unusual Items	489,919	448,618	663,243	204,623	32,112	64,586
Legal Settlements	-	-	-	-	-474.22	-2,955
Other Unusual Items	-4,142	-4,142	-5,541	-4,604	-	-
Pretax Income	485,777	444,476	657,701	192,626	27,227	53,225
Income Tax Expense	99,767	86,823	298,525	12,215	9,003	23,622
Earnings From Continuing Operations	386,009	357,653	359,176	180,411	18,224	29,603
Minority Interest in Earnings	-8,562	-4,410	-865.03	2,742	83.6	-52.22
Net Income	377,447	353,242	358,311	183,153	18,308	29,551
Net Income to Common	377,447	353,242	358,311	183,153	18,308	29,551
Net Income Growth	9.91%	-1.42%	95.63%	900.41%	-38.05%	49.92%
Basic Shares Outstanding	613	613	613	613	613	613
Diluted Shares Outstanding	613	613	613	613	613	613
Shares Change (YoY)	-	-	-	-	-	0.01%
EPS (Basic)	616.03	576.52	584.80	298.92	29.88	48.23
EPS (Diluted)	616.03	576.52	584.80	298.92	29.88	48.23
EPS Growth	9.91%	-1.42%	95.63%	900.41%	-38.05%	49.91%
Dividend Per Share	-	-	702.266	-	12.534	11.425
Dividend Growth	-	-	-	-	9.71%	179.98%
Effective Tax Rate	20.54%	19.53%	45.39%	6.34%	33.06%	44.38%

Updated May 21, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.

SEC Filings: 10-K · 10-Q